Browse Hematology/Oncology Articles by Topic

Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (Altuviiio)

Altuviiio can be prescribed to adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes, and perioperative bleeding management.

Identifying High-Risk Cancer Patients Through Appropriate Screening

Less than 20% of average-risk women receive guideline-adherent cervical cancer screening, and guideline-adherent screening was highest for primary HPV testing.

Mediterranean Diet Pairs Well with Immune Checkpoint Blockade

The popular healthy diet boosted response to unique cancer therapy among patients with advanced melanoma.

Ethical Problems with Rural Cancer Patients’ Access to Care

Patients and clinicians should discuss any available data regarding differences in care delivered at potential treatment sites, potential accompanying outcomes differences, and the costs and benefits of pursuing treatment at each site. Rural patient navigators should be involved in this discussion, considering the complexity of care coordination for patients with cancer.

Increasing Incidence of Stage IV Cervical Cancer

The incidence of stage IV cervical cancer in the United States between 2001 and 2018 increased. Rates were highest among Black women, but the annual rate of increase was highest among white women in the South age 40-44 years.

MicroRNA Could Help Oncologists Craft Better Treatment Plans for Breast Cancer Patients

Researchers have been searching for biomarkers that are good predictors of cancer recurrence and mortality.

Updated Recommendations on Pediatric End-of-Life Care

A report includes a review of essential elements of care for patients and families. The authors covered discussions on goals of care, how to establish end-of-life care goals, advance care planning, and palliative and hospice involvement.

Betibeglogene Autotemcel Suspension (Zynteglo)

The FDA has approved the first cell-based gene therapy to treat adult and pediatric patients with beta-thalassemia who require regular blood transfusions.

Parents, IRBs Hold Different Views on Phase I Pediatric Oncology Trials

IRB members are more likely than the public to think the risks outweigh the potential medical benefits. Parents think about the possibility of caring for a child with severe cancer and no treatment alternatives. IRBs ensure trials are ethical and that pediatric subjects are not exposed to excessive risk.

HPV Vaccination in Adolescence Prevents Cancer More than 10 Years Later

In a study of human papillomavirus (HPV) vaccination, researchers evaluated cancer protection over up to 11 years of follow-up. During this time, the authors noted 100% vaccine efficacy at preventing HPV-associated cancers.